cell and gene therapy world


IO Hub logo

Immuno-Hub: Solving clinical and bioprocessing challenges through innovation

Are you currently faced with challenges in cell-based manufacturing or getting a better patient response to your IO therapy? If so, our Immuno-Oncology Hub is where you need to be at this year’s Phacilitates Leaders Forum, taking you on a journey to explore innovation in these areas.

Phacilitate have bought together 6 technology innovators for a series of short 10 minute discussions focused on overcoming clinical and manufacturing challenges specific to IO biotechs.  Topics to be discussed in the hub include:


  • Precision medicine approaches
  • Biomarker solutions for patient response
  • Using genomics in your clinical trials
  • Next generation bioprocessing technologies


A guideline agenda can be found below: 

Cell-based manufacturing innovation



4:00 pm Gather at the IO hub
4:10 pm VGXI
4:20 pm Scinogy    
4:30 pm Maxcyte
4:40 pm Regroup and feed back
4:50 pm Drinks in the hub and networking
5:50 pm Phacilitate Yacht Party commences


Overcoming the patient response challenge: Precision Medicine and biomarker solutions



4:00 pm Gather at the IO hub
4:10 pm BD
4:20 pm Omniseq
4:30 pm Myriad RBM
4:40 pm Regroup and feed back
4:50 pm Drinks in the hub and networking
5:50 pm Phacilitate Yacht Party commences


  • "The event reflected the fantastic growing enthusiasm around cell and gene therapy, including small and large companies, investors and regulators. It was great to see everyone so engaged and so positive. The event really gives you the “pulse” of what is happening right now in cell and gene therapy."
    Anne-Virginie Eggimann,
  • “Great program, great people, great venue.”
    Klaus Kühlcke
    Managing Director, EUFETS GmbH
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.”
    Nathalie Clement
    Associate Director, Powell Gene Therapy Center, University of Florida
  • "Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field."
    Dr James Trager
    Vice President, Research & Product Development, Dendreon
  • "It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives."
    Kurt Gielen
    Acquisition & Business Development Manager, BioMedical Materials, Chemelot Campus B.V.
  • “Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.”
    Steven Goodman
    Director, Strategy and Engagement, GSK